Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression
From MaRDI portal
Publication:263555
DOI10.1016/J.BULM.2005.02.004zbMATH Open1334.92209OpenAlexW2030044358WikidataQ40407051 ScholiaQ40407051MaRDI QIDQ263555
Publication date: 5 April 2016
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.bulm.2005.02.004
Related Items (5)
Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification ⋮ Understanding drug resistance for monotherapy treatment of HIV infection ⋮ INFLUENCE OF DRUG PHARMACOKINETICS ON HIV PATHOGENESIS AND THERAPY ⋮ Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects ⋮ Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy
This page was built for publication: Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q263555)